Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …

Cushing disease caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary
corticotroph adenoma leads to hypercortisolaemia with high mortality due to metabolic …

Background Cushing's disease is a rare endocrine disorder characterised by cortisol
overproduction with severe complications. Therapies for cortisol reduction are often …

Transsphenoidal surgery (TSS) is the initial treatment modality of first choice in Cushing's
disease (CD). With microscopic TSS and endoscopic TSS, two operative techniques with …

Abstract Background The risk of Cushing syndrome (CS) patients experiencing a thrombotic
event (TE) is significantly higher (odds ratio; OR 18%) than that of the general population …

Transsphenoidal surgery is the first‐line treatment of Cushing's disease. However, medical
treatment can be given in a high proportion of patients with this rare condition. This is …

Cushing's syndrome (CS) is associated with increased mortality that is driven by
cardiovascular, thromboembolic, and infection complications. Although these events are …

Context Cushing syndrome (CS) results in significant morbidity and mortality. Objective To
study acute and life-threatening complications in patients with active CS. Methods We …

Endogenous/exogenous Cushing's syndrome is characterized by a cluster of systemic
manifestations of hypercortisolism, which cause increased cardiovascular risk. Its biological …

Cushing's disease recurrence following successful pituitary surgery is common and merits
prompt and careful diagnosis, as untreated hypercortisolism leads to increased morbidity …